title: AML drug resistance: c-Myc comes into play.
authors.affiliation: INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE.
authors.forename: Cyril
authors.initials: C
authors.lastname: Fauriat
authors.affiliation: INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE.
authors.forename: Daniel
authors.initials: D
authors.lastname: Olive
mesh_terms: D003602:Cytotoxicity, Immunologic / Q000235:genetics*; D058851:GPI-Linked Proteins / Q000235:genetics; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000235:genetics*; D047908:Intracellular Signaling Peptides and Proteins / Q000235:genetics*; D007694:Killer Cells, Natural / Q000276:immunology*; D015470:Leukemia, Myeloid, Acute / Q000235:genetics*; D016271:Proto-Oncogene Proteins c-myc / Q000502:physiology*
chemical_list: D058851:GPI-Linked Proteins; D036341:Intercellular Signaling Peptides and Proteins; D047908:Intracellular Signaling Peptides and Proteins; C489427:MYC protein, human; D016271:Proto-Oncogene Proteins c-myc; C423231:ULBP1 protein, human; C423230:ULBP2 protein, human; C423229:ULBP3 protein, human